Literature DB >> 17965226

Hirschsprung disease, associated syndromes and genetics: a review.

J Amiel1, E Sproat-Emison, M Garcia-Barcelo, F Lantieri, G Burzynski, S Borrego, A Pelet, S Arnold, X Miao, P Griseri, A S Brooks, G Antinolo, L de Pontual, M Clement-Ziza, A Munnich, C Kashuk, K West, K K-Y Wong, S Lyonnet, A Chakravarti, P K-H Tam, I Ceccherini, R M W Hofstra, R Fernandez.   

Abstract

Hirschsprung disease (HSCR, aganglionic megacolon) represents the main genetic cause of functional intestinal obstruction with an incidence of 1/5000 live births. This developmental disorder is a neurocristopathy and is characterised by the absence of the enteric ganglia along a variable length of the intestine. In the last decades, the development of surgical approaches has importantly decreased mortality and morbidity which allowed the emergence of familial cases. Isolated HSCR appears to be a non-Mendelian malformation with low, sex-dependent penetrance, and variable expression according to the length of the aganglionic segment. While all Mendelian modes of inheritance have been described in syndromic HSCR, isolated HSCR stands as a model for genetic disorders with complex patterns of inheritance. The tyrosine kinase receptor RET is the major gene with both rare coding sequence mutations and/or a frequent variant located in an enhancer element predisposing to the disease. Hitherto, 10 genes and five loci have been found to be involved in HSCR development.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17965226     DOI: 10.1136/jmg.2007.053959

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  303 in total

Review 1.  Genetic interactions and modifier genes in Hirschsprung's disease.

Authors:  Adam S Wallace; Richard B Anderson
Journal:  World J Gastroenterol       Date:  2011-12-07       Impact factor: 5.742

Review 2.  Voices from within: gut microbes and the CNS.

Authors:  Paul Forsythe; Wolfgang A Kunze
Journal:  Cell Mol Life Sci       Date:  2012-05-27       Impact factor: 9.261

3.  Hirschsprung's disease and variants in genes that regulate enteric neural crest cell proliferation, migration and differentiation.

Authors:  Tonia C Carter; Denise M Kay; Marilyn L Browne; Aiyi Liu; Paul A Romitti; Devon Kuehn; Mary R Conley; Michele Caggana; Charlotte M Druschel; Lawrence C Brody; James L Mills
Journal:  J Hum Genet       Date:  2012-05-31       Impact factor: 3.172

4.  Hirschsprung's disease, Down syndrome, and missing heritability: too much collagen slows migration.

Authors:  Robert O Heuckeroth
Journal:  J Clin Invest       Date:  2015-11-16       Impact factor: 14.808

Review 5.  Established and emerging concepts in Hirschsprung's-associated enterocolitis.

Authors:  Ankush Gosain
Journal:  Pediatr Surg Int       Date:  2016-01-19       Impact factor: 1.827

Review 6.  To bud or not to bud: the RET perspective in CAKUT.

Authors:  T Keefe Davis; Masato Hoshi; Sanjay Jain
Journal:  Pediatr Nephrol       Date:  2014-04       Impact factor: 3.714

7.  MicroRNA-4516-mediated regulation of MAPK10 relies on 3' UTR cis-acting variants and contributes to the altered risk of Hirschsprung disease.

Authors:  Yang Wang; Qian Jiang; Aravinda Chakravarti; Hao Cai; Ze Xu; Wenjie Wu; Beilin Gu; Long Li; Wei Cai
Journal:  J Med Genet       Date:  2020-02-17       Impact factor: 6.318

8.  Altered differentiation of enteric neural crest-derived cells from endothelin receptor-B null mouse model of Hirschsprung's disease.

Authors:  Naho Fujiwara; Katsumi Miyahara; Nana Nakazawa-Tanaka; Chihiro Akazawa; Atsuyuki Yamataka
Journal:  Pediatr Surg Int       Date:  2016-09-23       Impact factor: 1.827

9.  Hirschsprung-like disease is exacerbated by reduced de novo GMP synthesis.

Authors:  Jonathan I Lake; Olga A Tusheva; Brittany L Graham; Robert O Heuckeroth
Journal:  J Clin Invest       Date:  2013-11       Impact factor: 14.808

Review 10.  Trafficking of G-protein-coupled receptors to the plasma membrane: insights for pharmacoperone drugs.

Authors:  P Michael Conn; Alfredo Ulloa-Aguirre
Journal:  Trends Endocrinol Metab       Date:  2009-12-11       Impact factor: 12.015

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.